INTRODUCTION
Human growth hormone (hGH)' and human chorionic somatomammotropin (hCS) are closely related poly-peptide hormones with 92% homology between their mRNA coding sequences (1, 2) . Following digestion with EcoRI, the hGH and hCS genes are contained in 2.6-and 2.8-kilobase (kb) fragments of genomic DNA, respectively, while a third uncharacterized fragment (9.5 kb) contains homologous or "GH-like" (GH-L) sequences (2, 3) . Although all of these components of the hGH gene cluster are located on the long arm of chromosome 17, the arrangement of the components relative to each other is not known (3, 4) . Studies of the nucleotide sequences of isolated genomic clones suggest there are at least two types of hGH and two types of hCS genes (2, 5, 6) . One locus of hGH (hGH-N) encodes the known protein while another (hGH-V) encodes a protein with 14 amino acid differences from the normal, mature GH (7, 8) .
Human GH is synthesized and released by anterior pituitary cells under hypothalamic influence. Lack of hGH production causes metabolic alterations and growth failure (9) . Most cases of hGH deficiency are idiopathic, but there are several single gene disorders that are associated with an isolated deficiency or absence of hGH (10) . One form of familial isolated growth hormone deficiency (IGHD) is inherited as an autosomal dominant. Another form is X-linked recessive and is associated with hypogammaglobulinemia (11) . Finally, there are two forms (types I and IA) that have an autosomal recessive mode of inheritance. In type I, low but detectable levels of immunoassayable hGH may occur, but in type IA hGH secretion is absent due to the deletion of the hGH-N gene (7, 10, 12) .
One can postulate two explanations for the reduced hGH levels seen in IGHD type I (IGHD I): one involves mutations in or near the hGH genes, while the other involves mutations of distant loci that affect the embryological development, cellular composition, or neuroendocrine regulation of the anterior pituitary. In analogy to disorders of hemoglobin, a wide variety of hGH gene defects could cause an altered hGH polypeptide that would have decreased immunological and biological potency or a deficient amount of structurally normal hGH peptide (13) . Alternatively, IGHD I could be associated with normal hGH genes that are rendered nonfunctional by mutations of other "regulatory" loci that control functions of the hypothalamus and/or anterior pituitary cells (10) (11) (12) .
In contrast to IGHD IA, preliminary studies in our laboratories on DNA from individuals with IGHD I indicated that the hGH-N gene sequences were grossly normal. To determine if the hGH-N genes or their flanking sequences were subtly altered in IGHD I, we then used linkage analysis rather than DNA sequencing. We studied nine families with two affected sibs to determine if both affected children had inherited the same hGH-N gene from each parent. If the defect causing IGHD I were within or near the structural gene for growth hormone we should have found that each of the nine affected sib pairs was concordant for the hGH-N alleles inherited. We found that of the nine affected sib pairs studied, two pairs were concordant, three pairs were possibly concordant, and four pairs were discordant for the markers and, hence, the hGH-N alleles inherited. Since four of the nine sib pairs were discordant, we believe a large fraction of cases of IGHD I are due to defects that occur elsewhere in the genome. These results demonstrate the usefulness of linkage analysis in confirming that a mutation causing disease is within a specific gene before DNA sequencing of that gene.
METHODS
Clinical material. We studied DNA from members of nine families (A-I) whose pedigrees are shown in Fig. 4 Nuclear DNA preparation. High molecular weight DNA was prepared as described (14) from peripheral blood (10-30 ml) obtained from controls and all individuals shown in the pedigrees in Fig. 4 except the parents in family E, who were deceased.
Probe preparation. The recombinant plasmid chGH 800/ pBR 322 contains nearly full-length complementary DNA (cDNA) to hGH mRNA (15) . The 800-base pair (bp) hGH cDNA insert was isolated from pBR 322 DNA by HindIII digestion, followed by electrophoresis and recovery from agarose gels (16) . The purified 800-bp DNA fragment was labeled to a specific activity of -108 cpm/yg using [a-32PIdATP and [a-32P]deoxycytidine triphosphate ([a-32P]dCTP) by "nick translation" with Escherichia coli DNA polymerase I (17) . This probe was used in restriction analysis of DNA samples from all families except E and I. For samples from families E and I, the probe used was derived from the recombinant plasmid chCS 550/pMB9 that contains cDNA to hCS mRNA (18) . Experiments involving recombinant DNA were conducted at P2-EK2 containment in accordance with the National Institutes of Health guidelines.
Restriction endonuclease analysis. Aliquots of nuclear DNA prepared from individual family members and controls were digested to completion with various restriction endonucleases under conditions recommended by the commercial supplier (Bethesda Research Laboratories, Rockville, MD). Digested DNA and appropriate DNA size markers were subjected to electrophoresis in 0.8-1.25% (wt/vol) agarose gels. In some cases, genomic DNA fragments of a specific size were isolated from an agarose gel, digested with a second restriction endonuclease, and fractionated on a second agarose gel (19) . The DNA fragments were then transferred to nitrocellulose filters and hybridized with the hGH or hCS probe. The filters were then washed and autoradiographed (4, 20, 21 (7) . Thus, the isolated 26-kb fragment contains the GH-L and hGH-N genes (Fig. 3) . Similar procedures were used to show that the hGH-V and hCS genes are contained in the 23-and 16-kb fragments (data not shown). The polymorphic restriction sites, which yield 6.7/ 4.5-kb fragments after HincII digestion and 4.3/3.6-kb fragments after MspI digestion, are within the 26-kb HindIlI fragment and are thus physically linked to the hGH-N locus (Fig. 3) . The 23-and 16-kb HindIII fragments contain the hCS and hGH-V loci and the three remaining polymorphic restriction sites.
The exact location of the polymorphic HincIl site was determined by comparison of EcoRI plus HinclI digests of DNA from individuals who are homozygous for the presence or absence of the HinclI polymorphic site (4.5/4.5 or 6.7/6.7). The 2.6-kb EcoRI fragment, which contains the hGH-N gene, is cut to 2.15 kb in DNA from the 4.5/4.5 homozygotes but not in DNA from 6.7/6.7 homozygotes, indicating that the HinclI site is -0.45 kb from an EcoRI site flanking the gene (data not shown). Sequencing data of a cloned hGH-N gene (X hGH-N) further localizes the polymorphic HincII site 116 bp 5' to the -26 codon hGH-N.2 This site is not present in the hGH-N allele sequenced by DeNoto et al. (22) .
Results obtained after MspI or EcoRI plus MspI digestion of the 26-kb HindIlI generated fragment indicated that the polymorphic MspI site, which yields 4.3/3.6-kb fragments, is adjacent to the GH-L gene.
Since a genomic clone with an insert size of -17 kb has been described, which contains both the GH-L and the hGH-N genes (5), we calculate that the 4.3/3.6-kb polymorphic MspI site is at most 17 kb from the far end of the hGH-N gene.
Pedigree and linkage analysis. The pedigrees of the nine families with IGHD I whose DNA were studied are shown in Fig. 4 . Although all of these pedigrees are compatible with an autosomal recessive mode of inheritance, families A-D and I could also agree with an X-linked mode of inheritance. The hypogammaglobulinemia associated with the X-linked type of IGHD was excluded in affected males in families C and D by IgG, IgA, and IgM quantitation.
For each polymorphic restriction site we used in linkage analysis the large fragments occur in the absence of (-) and the small fragments in the presence of (+) the polymorphic restriction site. Thus, the fragments resulting from the absence of (-) or presence of (+) the various polymorphic restriction sites were designated as follows: HincIl (-6.7, +4. 
